The FDA has granted clearance to the expansion of Heidelberg Engineering’s Anterion platform, according to a press release.
“Building upon our previous CE-marking, we are thrilled that the Anterion platform is now available to eye care providers across the U.S.,” Arianna Schoess Vargas, managing director of Heidelberg Engineering GmbH, said in the release. “We believe this device complements our current portfolio of products and arms anterior segment-focused practices with the comprehensive data needed to support diagnostic decisions that ultimately improve patient care.”